Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_assertion type Assertion NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_head.
- NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_assertion wasGeneratedBy ECO_0000203 NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_provenance.
- NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_assertion wasDerivedFrom befree-2016 NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_provenance.
- NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_assertion SIO_000772 12619114 NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_provenance.
- NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_assertion evidence source_evidence_literature NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_provenance.
- NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_assertion description "[Specific emphasis is placed on genetic alterations and the prevalence of TP53 (p53) gene alterations in the distinct biological ovarian tumors (benign, borderline, and malignant) and histological subtypes (serous, mucinous, endometrioid, clear cell), as well as in BRCA1-associated hereditary ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385858.RAhrc9QGzmdkRTHsJlw8HNbhctGzvVOnrMu7sTyuTrp64130_provenance.